IIC
IBB icon

Integrated Investment Consultants’s iShares Biotechnology ETF IBB Stock Holding History

Integrated Investment Consultants’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-120
Closed -$13K – 415
2018
Q1 		$13K Buy
+120
New +$13.3K 0.01% 592

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Integrated Investment Consultants's IBB Position: Q2 2018 in Review

Integrated Investment Consultants sold out of iShares Biotechnology ETF (IBB) in Q2 2018, closing a stake of 120 shares — an estimated $13K sold.

Integrated Investment Consultants first reported a position in IBB in Q1 2018 and held it in 1 quarter. The position peaked at $13K in Q1 2018. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

  • Integrated Investment Consultants reported no remaining iShares Biotechnology ETF position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 120 iShares Biotechnology ETF shares in Q2 2018, an estimated $13K.
  • Integrated Investment Consultants first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 1 quarter.
  • Integrated Investment Consultants's iShares Biotechnology ETF position peaked at $13K in Q1 2018.
  • 609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.